SCHEMBL23701400

SCHEMBL23701400

CC12CN(C(=O)NCCO)CC1(C)CN(c1ccc(N3CCS(=O)(=O)CC3)cc1)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
KDM4E B2RXH2 1/20 0.43
ASAH1 Q13510 1/20 0.36
DRD2 P14416 4/20 0.36
DRD3 P35462 2/20 0.36
WNT3A P56704 1/20 0.35
DRD4 P21917 2/20 0.35
FAAH O00519 3/20 0.34
ITGB3 P05106 2/20 0.34
ITGA2B P08514 2/20 0.34
CTSL P07711 1/20 0.34
CTSB P07858 1/20 0.34
CTSS P25774 1/20 0.34
PRKD1 Q15139 1/20 0.33
NAMPT P43490 1/20 0.33
TGFBR1 P36897 1/20 0.33
ACVR1 Q04771 1/20 0.33
TP53 P04637 1/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23701399 1.00 ALDH1A1 (0.45) ALDH1A1KDM4EASAH1DRD2DRD3
SCHEMBL27400160 0.91 ALDH1A1 (0.45) ALDH1A1KDM4EASAH1DRD2DRD3
SCHEMBL23701390 0.88 ALDH1A1 (0.47) ALDH1A1KDM4EDRD2WNT3ADRD4
SCHEMBL23701387 0.88 ALDH1A1 (0.47) ALDH1A1KDM4EDRD2WNT3ADRD4
SCHEMBL23701371 0.82 GAA (0.46) ALDH1A1KDM4ETP53MEN1KMT2A
SCHEMBL23701368 0.82 GAA (0.46) ALDH1A1KDM4ETP53MEN1KMT2A
SCHEMBL23701437 0.80 KDM4E (0.55) ALDH1A1KDM4EWNT3AFAAHMEN1
SCHEMBL23701385 0.80 KMT2A (0.41) ALDH1A1KDM4EDRD2DRD4CTSL
SCHEMBL23701461 0.79 MAPT (0.41) ALDH1A1KDM4ETP53MEN1KMT2A
SCHEMBL23732563 0.79 KDM4E (0.50) ALDH1A1KDM4EFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018029-B2 Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2024-06-25 US disclosed
US-20210238179-A1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES USEFUL AS LOX INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12018029-B2 Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors LOX, LOXL1, LOXL3 ALDH1A1 765/4885KDM4E 685/4885ASAH1 943/4885
US-20210238179-A1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES USEFUL AS LOX INHIBITORS LOX, LOXL1, LOXL3 ALDH1A1 765/4885KDM4E 685/4885ASAH1 943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.